Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse

Psychopharmacology(2021)10.1007/s00213-020-05750-2Source: DataRank Database

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse is a research paper published in Psychopharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.12)OA: bronzeTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Eleanor Blair Towers,Wendy J. Lynch ORCID,Anousheh Bakhti‐Suroosh

Live enrichment

PubMed:33404740 PMC:PMC7786148 OpenAlex:https://openalex.org/W3119685613

National Institute on Drug Abuse

Grant: R01DA024716

National Institute on Drug Abuse

Grant: R01DA039093

NICHD NIH HHS

Grant: P50 HD028934

NIDA NIH HHS

Grant: R21 DA049992

NIGMS NIH HHS

Grant: T32 GM007267

FWCI

4.12

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

journalhttps://link.springer.com/content/pdf/10.1007/s00213-020-05750-2.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00213-020-05750-2.pdf

publisherhttps://link.springer.com/article/10.1007/s00213-020-05750-2/fulltext.html

journalhttps://doi.org/10.1007/s00213-020-05750-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33404740

Fields of Study

Neurotransmitter Receptor Influence on BehaviorOpioid Use Disorder TreatmentVeterinary Pharmacology and AnesthesiaAnimalsBuprenorphineConditioning, OperantDrug-Seeking BehaviorEstrusFemaleFentanylMaleOpioid-Related DisordersRatsRats, Sprague-DawleyRecurrenceSelf AdministrationSex Factors

MeSH Terms

AnimalsBuprenorphineConditioning, OperantEstrusFemaleFentanylMaleOpioid-Related DisordersRecurrenceSelf AdministrationSex FactorsRats, Sprague-DawleyRatsDrug-Seeking Behavior

Keywords

BuprenorphineOpioid use disorderAbstinenceFentanylSelf-administrationMedicineHeroinOpioidPsychologySubstance abuseAnesthesiaPsychiatryDrugInternal medicineTreatmentSex differencesIntermittent AccessAddiction-like Phenotype

Sustainable Development Goals

SDG 0: Good health and well-being

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)